Marinus Pharmaceuticals Inc (MRNS)
1.30
-0.03
(-2.26%)
USD |
NASDAQ |
May 16, 16:00
1.31
+0.01
(+0.77%)
Pre-Market: 08:55
Marinus Pharmaceuticals Cash from Investing (Quarterly): 20.88M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 20.88M |
| December 31, 2023 | 6.466M |
| September 30, 2023 | 11.92M |
| June 30, 2023 | 5.004M |
| March 31, 2023 | -52.00M |
| December 31, 2022 | 0.079M |
| September 30, 2022 | 106.11M |
| June 30, 2022 | -0.335M |
| March 31, 2022 | -0.086M |
| December 31, 2021 | -0.721M |
| September 30, 2021 | -0.872M |
| June 30, 2021 | -0.864M |
| March 31, 2021 | 1.042M |
| December 31, 2020 | 2.482M |
| September 30, 2020 | 2.982M |
| June 30, 2020 | 0.495M |
| March 31, 2020 | -6.697M |
| December 31, 2019 | 1.964M |
| September 30, 2019 | -0.255M |
| June 30, 2019 | -2.696M |
| March 31, 2019 | 4.868M |
| December 31, 2018 | 14.92M |
| September 30, 2018 | 5.002M |
| Date | Value |
|---|---|
| June 30, 2018 | 0.00 |
| March 31, 2018 | -0.008M |
| December 31, 2017 | 0.238M |
| September 30, 2017 | -24.69M |
| June 30, 2017 | 1.423M |
| March 31, 2017 | 1.612M |
| December 31, 2016 | 0.248M |
| September 30, 2016 | 1.253M |
| June 30, 2016 | -1.295M |
| March 31, 2016 | 1.19M |
| December 31, 2015 | 0.501M |
| September 30, 2015 | -4.972M |
| June 30, 2015 | -0.352M |
| March 31, 2015 | -1.491M |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | -0.003M |
| September 30, 2013 | -0.002M |
| June 30, 2013 | -0.008M |
| March 31, 2013 | -0.004M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-52.00M
Minimum
Mar 2023
106.11M
Maximum
Sep 2022
4.746M
Average
0.287M
Median
Cash from Investing (Quarterly) Benchmarks
| Ligand Pharmaceuticals Inc | -3.775M |
| Soligenix Inc | -- |
| Actinium Pharmaceuticals Inc | -0.011M |
| Macrogenics Inc | 24.79M |
| ADMA Biologics Inc | -2.362M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -37.46M |
| Cash from Financing (Quarterly) | 0.257M |
| Free Cash Flow | -113.98M |
| Free Cash Flow Per Share (Quarterly) | -0.6589 |
| Free Cash Flow to Equity (Quarterly) | -37.96M |
| Free Cash Flow Yield | -159.4% |